Synairgen Expands Share Capital with New Issuance
Company Announcements

Synairgen Expands Share Capital with New Issuance

Synairgen (GB:SNG) has released an update.

Synairgen plc, a UK-based respiratory company, has issued 1,285,722 new ordinary shares following the exercise of options by an ex-employee. These shares will begin trading on AIM on November 5, 2024, increasing the company’s total voting rights to 202,660,697. This move could impact shareholder interests and transparency requirements under FCA guidelines.

For further insights into GB:SNG stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks UK Auto-Generated NewsdeskSynairgen Appoints New Chairman, Advances Antiviral Treatment
TipRanks UK Auto-Generated NewsdeskSynairgen Prepares for Pivotal Phase 2 Trial
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App